Affiliation:
1. North Alabama Children's Specialists, 502 Governors
Drive, Huntsville, AL 35801, ebebin@peds.uab.edu
Abstract
Eight new anticonvulsant medications have been approved in the United States since 1993, offering physicians a greater range of options for treating children with partial and generalized seizures. However, pediatric neurologists have been faced with limited pediatric pharmacokinetic and pharmacodynamic information. This article reviews the newer antiepilepsy drugs—gabapentin, felbamate, lamotrigine, topiramate, oxcarbazepine, levetiracetam, and zonisamide—and summarizes what is currently known about the safety and efficacy of these drugs in treating partial and generalized seizures in the pediatric population. Further studies are needed, however, to thoroughly evaluate their efficacy and safety in children. (J Child Neurol 2002;17:S65—S69).
Subject
Clinical Neurology,Pediatrics, Perinatology, and Child Health
Reference31 articles.
1. Annegers JF: The epidemiology of epilepsy, in Wyllie E (ed): The Treatment of Epilepsy, 3rd ed. Philadelphia, Lippincott Williams and Wilkins, 2001, 131—138.
2. Arunkumar G., Kotogal P., Rothner D.: Localization-related epilepsies: Simple partial seizures, complex partial seizures, benign focal epilepsy of childhood and epilepsia partialis continua , in Pellock J, Dodson EW, Bourgeois BF (eds): Pediatric Epilepsy Diagnosis and Therapy. New York, Raven, 2001, 243—264.
3. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
4. Oxcarbazepine
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献